Publications by authors named "Thomas Strack"

Claim this Profile
C
Combinatorial Efficacy and Toxicity of an Engineered Toxin Body MT-3724 with Gemcitabine and Oxaliplatin in Relapsed or Refractory Diffuse Large B Cell Lymphoma.
Chenyu Lin, Ahmed Galal, David Rizzieri, Sant Chawla, Seung T Lee, Thomas Strack

Cancer Invest· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma.
Paul A Hamlin, Vasile Musteata, Steven I Park, Christine Burnett, Kristina Dabovic, Thomas Strack

Cancer Res Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma.
Richard B Noto, Daniel A Pryma, Jessica Jensen, Tess Lin, Nancy Stambler, Thomas Strack

J Clin Endocrinol Metab· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Study of Tc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection.
Karolien E Goffin, Steven Joniau, Peter Tenke, Kevin Slawin, Eric A Klein, Thomas Strack

J Nucl Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trials.
Nick Freemantle, Thomas Strack

J Clin Epidemiol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetics of alternative insulin delivery systems.
Thomas Strack

Curr Opin Investig Drugs· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and characterization of rhenium and technetium-99m labeled insulin.
Chitra Sundararajan, Travis R Besanger, Renee Labiris, Katharina J Guenther, Thomas Strack

J Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic exposure is affected favorably by inhaled human insulin (Exubera) as compared with subcutaneous insulin glargine (Lantus) in patients with type 2 diabetes.
Marcus Hompesch, Alexa Kollmeier, Klaus Rave, Lutz Heinemann, Michael Mitnick, Thomas Strack

Diabetes Technol Ther· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled insulin is associated with prolonged enhancement of glucose disposal in muscle and liver in the canine.
Dale S Edgerton, Alan D Cherrington, Doss W Neal, Melanie Scott, Margaret Lautz, Thomas R Strack

J Pharmacol Exp Ther· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design.
Thomas Strack, Luc Martinez, Stefano Del Prato, Larry Blonde, Burkhard Göke

Diabetes Metab Syndr Obes· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging as a tool in drug development.
Thomas Strack

Drugs Today (Barc)· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation of human insulin is associated with improved insulin action compared with subcutaneous injection and endogenous secretion in dogs.
Dale S Edgerton, Kathryn M Stettler, Doss W Neal, Melanie Scott, Larry Bowen, Thomas R Strack

J Pharmacol Exp Ther· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation of human insulin (exubera) augments the efficiency of muscle glucose uptake in vivo.
Dale S Edgerton, Alan D Cherrington, Phillip Williams, Doss W Neal, Melanie Scott, Thomas R Strack

Diabetes· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will availability of inhaled human insulin (Exubera) improve management of type 2 diabetes? The design of the Real World trial.
Nick Freemantle, Thomas R Strack,

Trials· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled human insulin.
Thomas R Strack

Drugs Today (Barc)· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and in vitro evaluation of 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies.
Katharina J Guenther, Sabesan Yoganathan, Robert Garofalo, Thomas Kawabata, Thomas Strack

J Med Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation of insulin (Exubera) is associated with augmented disposal of portally infused glucose in dogs.
Dale S Edgerton, Doss W Neal, Melanie Scott, Larry Bowen, Warren Wilson, Thomas R Strack

Diabetes· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation of insulin in dogs: assessment of insulin levels and comparison to subcutaneous injection.
Alan D Cherrington, Doss W Neal, Dale S Edgerton, Dana Glass, Larry Bowen, Thomas R Strack

Diabetes· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis